Concepedia

Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention

Marco Valgimigli, Matteo Tebaldi, Marco Borghesi, Pascal Vranckx, Gianluca Campo, Carlo Tumscitz, Elisa Cangiano, Monica Minarelli, Antonella Scalone, Caterina Cavazza,

JACC: Cardiovascular Interventions · 2013 · 138 citations · 24 references

DOI

Concepts

References

24

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Gregg W. Stone, Stephen G. Ellis, David A. Cox et al. · New England Journal of Medicine · 2004 · 2.7K citations · Full text

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

Sam Ellis, Michel Vandormael, Michael J. Cowley et al. · Circulation · 1990 · 1.3K citations

, , +22

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Gregg W. Stone, Ali A. Rizvi, William Newman et al. · New England Journal of Medicine · 2010 · 886 citations · Full text

Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation

Eric L. Eisenstein, Kevin J. Anstrom, David F. Kong et al. · JAMA · 2006 · 870 citations